此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

A Home-based Blood Pressure Monitoring Program to Promote Better Management of Hypertension

2013年6月10日 更新者:Tehran University of Medical Sciences

A Home-based Blood Pressure Measurement Program in Hypertensive Patients to Promote Medications Adherence and Blood Pressure Status.

In this study the investigators aim to evaluate the effect of home-based blood pressure measurement with an electronic device on medication adherence and blood pressure control.

研究概览

详细说明

Adherence to treatment is disappointingly low among patients with chronic health disorders especially after 6 month of initiating drug therapy. In hypertensive patients , as reported by WHO, 50% of non-adherence could be expected. Poor adherence to anti hypertensive medications results in increased morbidity, mortality and costs. One of the reasons that could implicate medications adherence can be attributed to seeing no physical sign of better controlling blood pressure. Self monitoring of blood pressure at home has been reported to improve patients adherence to their medications.

This study is a 2-arm randomized controlled trial. The investigators aim to evaluate the effect of home-based blood pressure measurement with an electronic device on medication adherence and blood pressure status.

One hundred ninety six hypertensive patients aged at least 18 years old are recruited in an ambulatory care setting and are evenly allocated to the study arms with balanced-block telephone randomization.

Appropriate medication is prescribed as preferred by the cardiologist (single daily dose medicines are recommended). Patients in both arms are followed for 24 weeks, each will be visited by the cardiologist four times during the study period. In each visit, patients' blood pressure will be measured twice by a nurse in the office.

In the intervention arm, electronic blood pressure device is provided for each patient and he/she will be trained to measure blood pressure at home once daily (same time each day). A logbook is also provided to document the daily blood pressure level.

Primary outcome of the study is the blood pressure measured at each office visit overtime. Medication adherence is measured by pill count method as the secondary outcome.

研究类型

介入性

注册 (实际的)

196

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Ambulatory patients older than 18
  • Patients newly diagnosed as hypertension stage 1
  • Patients previously on antihypertensive treatment but uncontrolled hypertension
  • Patients not possessing electronic self blood pressure measurement device
  • Patients with functional ability to use the device

Exclusion Criteria:

  • Patients requiring two or more antihypertensive drugs at the start of the study
  • Patients with secondary hypertension
  • Patients cardiovascular comorbidities and other interfering medical conditions
  • Patients with drug contraindication or documented drug allergy
  • Patients with serum creatinine > 150 microliters

Withdrawal criteria:

  • Inadequate therapeutic effect requiring an increase of more than 20% in pre-established number of visits
  • Emergence of adverse drug reactions requiring cessation of medication

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Home-based blood pressure monitoring
Electronic blood pressure device is provided for patients and he/she will be trained to measure blood pressure at home once daily(same time each day). A logbook is also provided to document the daily blood pressure level.
有源比较器:日常护理
Four visits to the physician's office at 4th, 12th, 24th week in the study period with usual advice giving practice of the staff. At the end of the trial period, an electronic blood pressure device will be given to each patient in this arm.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Blood pressure-24 weeks
大体时间:Change from baseline(at the point of recruiting) blood pressure at 24 weeks.
Blood pressure is measured twice by trained nurses using hand-cuff device at the physician office. (in Hg millimeter)
Change from baseline(at the point of recruiting) blood pressure at 24 weeks.

次要结果测量

结果测量
措施说明
大体时间
Medication adherence-4 weeks
大体时间:Change from baseline(at the point of recruiting) medication adherence at 4 weeks
Change from baseline(at the point of recruiting) medication adherence at 4 weeks
Blood pressure- 4 weeks
大体时间:Change from baseline(at the point of recruiting) blood pressure at 4 weeks.
Change from baseline(at the point of recruiting) blood pressure at 4 weeks.
Blood pressure- 12 weeks
大体时间:Change from baseline(at the point of recruiting) blood pressure at 12 weeks.
Change from baseline(at the point of recruiting) blood pressure at 12 weeks.
Medication adherence- 12 weeks
大体时间:Change from baseline(at the point of recruiting) medication adherence at 12 weeks
Change from baseline(at the point of recruiting) medication adherence at 12 weeks
Medication adherence-24 weeks
大体时间:Change from baseline(at the point of recruiting) medication adherence at 24 weeks
Pill count method is employed. At the time of each office visit, patients bring their medications with themselves and the researcher counts the unused pills. Adherence is calculated as percentage of the pills used during previous weeks.
Change from baseline(at the point of recruiting) medication adherence at 24 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Kheirollah Gholami, M.Sc,PharmD、Tehran University of Medical Sciences
  • 研究主任:Zahra Jahangard-Rafsanjani, PharmD、Tehran University of Medical Sciences
  • 首席研究员:Arash Rashidian, M.D, Ph.D、Tehran University of Medical Sciences

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年3月1日

初级完成 (实际的)

2012年9月1日

研究完成 (实际的)

2013年3月1日

研究注册日期

首次提交

2012年1月30日

首先提交符合 QC 标准的

2012年2月1日

首次发布 (估计)

2012年2月2日

研究记录更新

最后更新发布 (估计)

2013年6月11日

上次提交的符合 QC 标准的更新

2013年6月10日

最后验证

2013年6月1日

更多信息

与本研究相关的术语

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅